CSIMarket Company Name, Ticker, Suppliers, else..
 
Rxsight Inc   (RXST)
Other Ticker:  
 
 
Price: $56.1400 $0.60 1.080%
Day's High: $57.53 Week Perf: 2.93 %
Day's Low: $ 55.45 30 Day Perf: 6.35 %
Volume (M): 345 52 Wk High: $ 66.54
Volume (M$): $ 19,357 52 Wk Avg: $45.88
Open: $55.96 52 Wk Low: $20.66



 Market Capitalization (Millions $) 2,002
 Shares Outstanding (Millions) 36
 Employees -
 Revenues (TTM) (Millions $) 75
 Net Income (TTM) (Millions $) -55
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 4

Rxsight Inc
RxSight Inc. is a medical technology company that specializes in developing and manufacturing intraocular lens (IOL) systems for cataract patients. The company has developed an innovative IOL platform called the Light Adjustable Lens (LAL), which allows for postoperative adjustments to the lens power and corrects residual refractive errors. This technology helps patients achieve better visual outcomes after cataract surgery. RxSight Inc. was founded in 1998 and is headquartered in California, United States.


   Company Address: 100 Columbia Aliso Viejo 92656 CA
   Company Phone Number: 521-7830   Stock Exchange / Ticker: NASDAQ RXST


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Financing Agreement

RxSight, Inc. Enhances Tangible Leverage Ratio and Successfully Closes Public Offering, Driving Innovation in Ophthalmic Medical Devices

Published Mon, May 13 2024 8:05 PM UTC

RxSight, Inc. Enhances Tangible Leverage Ratio, Closing Successful Public Offering of Common Stock
Aliso Viejo, Calif. - May 13, 2024 - RxSight, Inc. (Nasdaq: RXST), a leading ophthalmic medical device company specializing in customized vision solutions for patients post-cataract surgery, has successfully closed its underwritten public offering of common stock. The offer...
Shares

RxSight, Inc. Prices Underwritten Public Offering, Anticipates $100.0 Million in Gross Proceeds

Published Thu, May 9 2024 1:15 AM UTC



ALISO VIEJO, Calif., May 08, 2024 (NASDAQ: RXST) ?? RxSight, Inc., a leading ophthalmic medical device company specializing in providing personalized vision solutions post cataract surgery, announced today the pricing of its underwritten public offering. The company is planning to sell 1,785,714 shares of its common stock at $56.00 per share to the public. This mov...
Financing Agreement

RxSight, Inc. Seeks $100 Million Funding in Public Offering to Propel Vision Solutions for Cataract Surgery Patients

Published Wed, May 8 2024 8:05 PM UTC

RxSight, Inc. Aims to Raise $100 Million in Public Offering to Fuel Expansion and Innovation
ALISO VIEJO, Calif. - RxSight, Inc. (Nasdaq: RXST), a leading ophthalmic medical device company specializing in personalized vision solutions for patients post-cataract surgery, announced its intention to conduct an underwritten public offering of its common stock. The company pl...
Product Service News

?RxSight Showcases Innovation in Customized Vision with the Launch of its Revolutionary Light Adjustable Lens+

Published Thu, Apr 4 2024 8:05 PM UTC

RxSight, Inc., an industry-leading ophthalmic medical device firm committed to providing patients with customized vision after cataract surgery, announced the commercial availability of its most revolutionary product yet, the Light Adjustable Lens+ (LAL+). This announcement, made on April 04, 2024, emphasizes the company's relentless commitment to pioneering innovative solut...
Stock Market Announcement

RxSight, Inc. Achieves Stellar Financial Performance in 2023 and Shows Promising Outlook for 2024.

Published Sun, Jan 7 2024 3:00 PM UTC



RxSight, Inc., a leading ophthalmic medical device company, has recently revealed their preliminary unaudited financial and operational results for the fourth quarter and full-year 2023. Additionally, the company provided guidance for the upcoming year, projecting a bright future. This article aims to outline the notable facts from the press release and assess the...






Rxsight Inc's Segments





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com